Dongwha, Novartis Korea sign OTC deal

Dongwha Pharmaceutical and Novartis Korea recently established a strategic alliance to co-market the whole range of the latter’s over-the-counter (OTC) drugs in Korea.

These OTC medicines include Lamisil (terbinafine), Otribin (xylometazoline), Nicotine-L, Voltaren (diclofenac) and Theraflu.

Industry watchers expect the domestic OTC drugs market is about to heat up, as Novartis has joins...